Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?
Adam Jameson, Beth Fylan, Greg C. Bristow, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

The emergence, implementation, and future growth of pharmacogenomics in psychiatry: a narrative review
Chad A. Bousman, Abdullah Al Maruf, Diogo Marques, et al.
Psychological Medicine (2023) Vol. 53, Iss. 16, pp. 7983-7993
Open Access | Times Cited: 21
Characterizing pharmacogenetic programs using the consolidated framework for implementation research: A structured scoping review
John McDermott, Stuart Wright, Videha Sharma, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 24
An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean
Aimeé Salas-Hernández, Macarena Galleguillos, Matías Carrasco, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16
Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States
Lauren Lemke, Benish Alam, Roy Williams, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
QPGx‐CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies
Rania G. Abdel‐latif, Radja Badji, Shaban Mohammed, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 6
Open Access | Times Cited: 4
Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned
Tyler Shugg, Emma M. Tillman, Amy M. Breman, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 4, pp. 914-931
Open Access | Times Cited: 4
Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals
Angela Pearce, Bronwyn Terrill, Jan‐Willem C. Alffenaar, et al.
Internal Medicine Journal (2022) Vol. 52, Iss. 7, pp. 1135-1143
Open Access | Times Cited: 19
The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
Susanne B. Haga
Pharmacy (2023) Vol. 11, Iss. 5, pp. 144-144
Open Access | Times Cited: 10
Exploring perceived barriers and attitudes in young adults towards antidepressant pharmacotherapy, including the implementation of pharmacogenetic testing to optimize prescription practices
Bradley Roberts, Zahra Cooper, Georgia Landery, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Solanidine‐derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patients
Jens Andreas Sarömba, Julian Peter Müller, Jolanta Tupiec, et al.
British Journal of Clinical Pharmacology (2025)
Open Access
A feasibility study on implementing pre-emptive pharmacogenomics testing in outpatient clinics in Singapore (IMPT study)
Fiona FJ Ng, Rashmi Verma, Levana Sani, et al.
The Pharmacogenomics Journal (2025) Vol. 25, Iss. 1-2
Open Access
Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic
Abdullah Al Maruf, Chad A. Bousman
Psychiatry and Clinical Neurosciences Reports (2022) Vol. 1, Iss. 2
Closed Access | Times Cited: 14
Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
Bradley Roberts, Zahra Cooper, Stephanie Lu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Mental Health Prescribers’ Perceptions on the Use of Pharmacogenetic Testing in the Management of Depression in the Middle East and North Africa Region
Shimaa Aboelbaha, Monica Zolezzi, Oraib Abdallah, et al.
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 503-518
Open Access | Times Cited: 7
A proposal for reducing maximum target doses of drugs for psychosis: Reviewing dose–response literature
James R. O’Neill, Adam Jameson, Samantha L. McLean, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 4, pp. 344-352
Open Access | Times Cited: 2
Pharmacogenomic Testing to Guide Treatment of Major Depressive Disorder: A Systematic Review
Farah Khorassani, Mandy Jermain, Christine Cadiz
Current Treatment Options in Psychiatry (2024) Vol. 11, Iss. 2, pp. 123-140
Open Access | Times Cited: 2
Pharmacogenetic testing in primary care could bolster depression treatment: A value proposition
Nina Sperber, Megan C. Roberts, Sarah Gonzales, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 6
Open Access | Times Cited: 2
Healthcare provider and patient perspectives on the implementation of pharmacogenetic-guided treatment in routine clinical practice
Gurveer Kaur, Chukwunonso K. Nwabufo
Pharmacogenetics and Genomics (2024)
Closed Access | Times Cited: 2
An Overview of Pharmacogenomic Testing for Psychiatric Disorders
Calvin Young, Danielle MacDougall
Canadian Journal of Health Technologies (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 6
Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service
Chiara Jeiziner, Henriette E. Meyer zu Schwabedissen, Kurt E. Hersberger, et al.
International Journal of Clinical Pharmacy (2023) Vol. 45, Iss. 6, pp. 1378-1386
Open Access | Times Cited: 6
Pharmacogenomics to support mental health medication therapy management: Clinical practice considerations and a conceptual framework to enhance patient care
Jeffrey R. Bishop, Mark E. Schneiderhan, Tiana Butler, et al.
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2023) Vol. 7, Iss. 2, pp. 160-170
Open Access | Times Cited: 6
Best–worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy
Ramzi G. Salloum, Jeffrey R. Bishop, Amanda L. Elchynski, et al.
Implementation Science Communications (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 10
Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates
Zeina N. Al-Mahayri, Lubna Q. Khasawneh, Mais N. Alqasrawi, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 8
A Narrative Review on Pharmacogenomics in Psychiatry
Sara Palumbo, Veronica Mariotti, Silvia Pellegrini
Journal of Clinical Psychopharmacology (2023) Vol. 44, Iss. 1, pp. 49-56
Open Access | Times Cited: 4
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification
Morten Baltzer Houlind, Luise Hansen, Esben Iversen, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 5, pp. 756-763
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top